These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 1509795)

  • 21. [Therapy of ventricular arrhythmias with propafenone].
    Petri H; Kafka W; Rudolph W
    Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Continuous ventricular tachyarrhythmia in patients without detectable organic heart disease: clinical and electrophysiologic findings].
    Schöls W; Brachmann J; Schmitt C; Waldecker B; Kübler W
    Z Kardiol; 1989 Dec; 78(12):790-6. PubMed ID: 2623922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs?].
    Steinbeck G
    Z Gesamte Inn Med; 1992 May; 47(5):195-201. PubMed ID: 1615729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic and electrophysiologic effects of encainide in patients with bundle branch block.
    Schwartz AB; Shapiro WA; Suave MJ; Shen E; Bhandari A; Morady F; Scheinman M
    Can J Cardiol; 1987 Mar; 3(2):75-82. PubMed ID: 3105850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of ventricular tachycardia by endocavitary stimulation. Apropos of 46 cases].
    Cassagneau B; Calazel J; Puel J; Fauvel JM; Bounhoure JP; Marin T; Narula OS
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):652-60. PubMed ID: 6431929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
    Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
    Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complex ventricular extrasystole. Value of technics of programmed electric stimulation].
    Metge M; Lévy S; Cointe R; Agabriel P; Bru P; Gérard R
    Arch Mal Coeur Vaiss; 1987 Dec; 80(13):1893-8. PubMed ID: 2452620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents].
    Kuck KH
    Z Kardiol; 1992; 81 Suppl 4():151-5. PubMed ID: 1283932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction.
    Seals AA; Haider R; Leon C; Francis M; Young JB; Roberts R; Pratt CM
    Circulation; 1987 Apr; 75(4):800-8. PubMed ID: 3549044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravenous cibenzoline on ventricular vulnerability and electrophysiology in patients with sustained ventricular tachycardia in comparison to a control group.
    Kühlkamp V; Schmid F; Mayer F; Ickrath O; Haasis R; Seipel L
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):472-5. PubMed ID: 1691372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D; Ishibashi K; Sakai R; Inoue M; Omori I; Asayama J; Nakagawa M
    Kokyu To Junkan; 1992 Dec; 40(12):1203-8. PubMed ID: 1480832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study.
    Kostis JB; Krieger S; Moreyra A; Cosgrove N
    J Am Coll Cardiol; 1984 Aug; 4(2):372-7. PubMed ID: 6376595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN; Saksena S
    Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of intravenous cibenzoline for acute termination of spontaneous sustained ventricular tachycardia. Cibenzoline and spontaneous VT.
    Chevalier P; Dacosta A; Chalvidan T; Bonnefoy E; Kirkorian G; Isaaz K; Touboul P
    Int J Cardiol; 1998 May; 64(3):265-70. PubMed ID: 9672407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.